These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31242525)

  • 1. Competing Endogenous RNAs in Hepatocellular Carcinoma-The Pinnacle of Rivalry.
    Afify AY; Ibrahim SA; Aldamsisi MH; Zaghloul MS; El-Ekiaby N; Abdelaziz AI
    Semin Liver Dis; 2019 Nov; 39(4):463-475. PubMed ID: 31242525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing endogenous RNA: the key to posttranscriptional regulation.
    Sen R; Ghosal S; Das S; Balti S; Chakrabarti J
    ScientificWorldJournal; 2014; 2014():896206. PubMed ID: 24672386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma.
    Niu ZS; Wang WH; Dong XN; Tian LM
    World J Gastroenterol; 2020 Aug; 26(29):4240-4260. PubMed ID: 32848331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIK3C2A mRNA functions as a miR-124 sponge to facilitate CD151 expression and enhance malignancy of hepatocellular carcinoma cells.
    Liu T; Zu CH; Wang SS; Song HL; Wang ZL; Xu XN; Liu HS; Wang YL; Shen ZY
    Oncotarget; 2016 Jul; 7(28):43376-43389. PubMed ID: 27270320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Analysis of P53-Mediated Competing Endogenous RNA Network in Human Hepatocellular Carcinoma.
    Zhang Y; Kang R; Liu W; Yang Y; Ding R; Huang Q; Meng J; Xiong L; Guo Z
    Int J Biol Sci; 2017; 13(9):1213-1221. PubMed ID: 29104512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ceRNA in cancer: possible functions and clinical implications.
    Qi X; Zhang DH; Wu N; Xiao JH; Wang X; Ma W
    J Med Genet; 2015 Oct; 52(10):710-8. PubMed ID: 26358722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Long Non-Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA-664.
    He JH; Han ZP; Liu JM; Zhou JB; Zou MX; Lv YB; Li YG; Cao MR
    J Cell Biochem; 2017 Nov; 118(11):3713-3721. PubMed ID: 28374914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Identification of Cross-Talking ceRNAs.
    Li Y; Huo C; Lin X; Xu J
    Adv Exp Med Biol; 2018; 1094():97-108. PubMed ID: 30191491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma.
    Xu G; Xu WY; Xiao Y; Jin B; Du SD; Mao YL; Zhang ZT
    Cancer Cell Int; 2020; 20():496. PubMed ID: 33061848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The miRNA-mediated cross-talk between transcripts provides a novel layer of posttranscriptional regulation.
    Tan JY; Marques AC
    Adv Genet; 2014; 85():149-99. PubMed ID: 24880735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miRNA sponges in hepatocellular carcinoma.
    Li D; Zhang J; Li J
    Clin Chim Acta; 2020 Jan; 500():10-19. PubMed ID: 31604064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncoding RNA:RNA Regulatory Networks in Cancer.
    Chan JJ; Tay Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
    Wong CM; Tsang FH; Ng IO
    Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous miRNA Sponges.
    Alkan AH; Akgül B
    Methods Mol Biol; 2022; 2257():91-104. PubMed ID: 34432275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttranscriptional Regulation of PTEN by Competing Endogenous RNAs.
    Tay Y; Pandolfi PP
    Methods Mol Biol; 2016; 1388():139-54. PubMed ID: 27033075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.